Definitely what you like to see before results due. I find it hard to believe Mt Marion will be a dud, not expecting anything crazy but the fact MC is only sitting at around 10 million, most certainly a buy. LRD only makes up roughly 5% of my portfolio, but the upside on this is hard to ignore. Will add more pending assays that should be due this week or the next.
